
Click to enlarge
BONSS RF Plasma Generator / Cutting Loop / Urologic Surgical Instruments
Jiangsu, ChinaJiangsu Bonss Medical Technology Co., Ltd.
$1027.84
MOQ5 Minimum
Lead Time
| Quantity | 旺季 | 淡季 |
|---|---|---|
| 1 - 1000 | 25 days | 25 days |
| > 1000 | To be negotiated | To be negotiated |
Product profile
- Function
- Surgical Unit
- Name
- RF Plamsa Electrode
- Instrument classification
- Class II
- Safety standard
- None
- Place of Origin
- Jiangsu, China
- Model Number
- AC
- Power Source
- Electricity
- Material
- Metal, Plastic
- After-sale Service
- Online Technical Support
- Brand Name
- BONSS
- Single package size
- 40X39X13 cm
- Weight
- 0.5kg/9kg
- Shelf Life
- 1years
- Supply Ability
- 1000 pieces per Month
- Quality Certification
- CE
- Usage
- saline irrgation, suction,ablation,coagulation,hemostasis
- Application
- ablation therapy
- Packaging Details
- plastic tray+color box
- Single gross weight
- 15.000 kg
- Temperature
- 40-70
- Warranty
- 1 Year
- Feature
- Minimally Invasive
- Charactor
- bipolar, multi-polar
- Certificate
- CE ISO13485
- Technology
- Innovative RF Plasma
- Selling Units
- Single item
Company profile

Jiangsu Bonss Medical Technology Co., Ltd.
邦士医疗科技股份有限公司Jiangsu, ChinaBuilding 7, Phase I Standard Factory Building, No. 898 Yaocheng Avenue, Taizhou City (business premises: Northwest corner 1F and 2F, Building 5, Phase I Standard Factory Building, No. 898 Yaocheng Avenue, Taizhou City) Taizhou Jiangsu China- CertifiedTrade Assurance
- Business Type: Manufacturer, Trading Company
- Established: 2013
- Employees: 301 - 500 People
- Plant Area: 5,000-10,000 square meters
- Annual Export Value: US$5 Million - US$10 Million
- Avg. Response Time: ≤ 17h
Main Products
- Radio Frequency Plasma Surgical Systems; Radio Frequency Plasma Surgical Electrodes
- Surgical Power Systems; Shaver Blades
Main Markets
Domestic Market(68.00%), South Asia(6.00%), South America(5.00%), Mid East(5.00%), Southeast Asia(5.00%), Eastern Asia(2.00%), North America(2.00%), Oceania(1.00%), Africa(1.00%), Southern Europe(1.00%), Northern Europe(1.00%), Central America(1.00%), Western Europe(1.00%), Eastern Europe(1.00%)





























